Farxiga

Farxiga (dapagliflozin) is a medication used to treat high blood sugar levels in individuals with type 2 diabetes (it is not approved for the treatment of individuals with type 1 diabetes). Farxiga is also effective in reducing hospitalization for heart failure and the risk of death from heart failure. It is taken orally and should be combined with diet and exercise to help control high blood sugar levels.

Farxiga should not be used by individuals with ketoacidosis, a condition that increases ketones in the urine and blood. Patients suffering from bladder cancer or certain kidney diseases should also avoid Farxiga.

Farxiga can cause weight loss and feelings of fatigue. It’s important to monitor for potential dehydration while taking Farxiga. Your doctor may also monitor for thrush or infections in the urinary tract since Farxiga raises glucose levels in the urine, which can increase the risk of infection.